After a year of dwindling coffers and repeated layoff rounds, the Southern California biotech firm Viracta Therapeutics has ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

Aurion Biotech, Inc. (Aurion), whose mission is to restore vision to millions of patients with life-changing regenerative ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Janney Montgomery Scott LLC purchased a new position in VanEck Biotech ETF (NASDAQ:BBH – Free Report) during the fourth ...

News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

One of Cincinnati’s best-funded startups further cemented its place on that list last year.

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Learn more about whether Legend Biotech Corporation or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.